Journal of the Chinese Medical Association

Journal of the Chinese Medical Association is published by Elsevier Taiwan LLC and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Liver Disease and Transplantation, Human auditory perception and evaluation and Liver Disease Diagnosis and Treatment, together about 18.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Journal of the Chinese Medical Association, previously known as the Chinese Medical Journal (Taipei), has a long history of publishing scientific papers and has continuously made substantial contribution in the understanding and progress of a broad range of biomedical sciences. It is published monthly by Wolters Kluwer Health and indexed in Science Citation Index Expanded (SCIE), MEDLINE®, Index Medicus, EMBASE, CAB Abstracts, Sociedad Iberoamericana de Informacion Cientifica (SIIC) Data Bases, ScienceDirect, Scopus and Global Health. JCMA is the official and open access journal of the Chinese Medical Association, Taipei, Taiwan, Republic of China and is an international forum for scholarly reports in medicine, surgery, dentistry and basic research in biomedical science. As a vehicle of communication and education among physicians and scientists, the journal is open to the use of diverse methodological approaches. Reports of professional practice will need to demonstrate academic robustness and scientific rigor. Outstanding scholars are invited to give their update reviews on the perspectives of the evidence-based science in the related research field. Article types accepted include review articles, original articles, case reports, brief communications and letters to the editor

Source: LetPub

Research area (LetPub): MEDICINE, GENERAL & INTERNAL

Editor-in-chief Shuu-Jiun WangPublisher website

CAS Journal Ranking

JCR / CiteScore quartiles on the journal's website

• JCR Q2 · MEDICINE, GENERAL & INTERNAL · rank 99/336

Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

2.23LetPub · 2026-09-13

Impact factor (publisher)

2.3Publisher website · 2026-09-29

CiteScore 2026-06

4.3LetPub · 2026-09-13

SJR 2026-06

0.46LetPub · 2026-09-13

SNIP 2026-06

0.66LetPub · 2026-09-13

h-index

37LetPub · 2026-09-13

h-index

64OpenAlex · 2026-10-01

i10-index

1,446OpenAlex · 2026-10-01

2-year mean citedness

2.85OpenAlex · 2026-10-01

Self-citation rate

13%LetPub · 2026-09-13

Share of gold OA articles

98.99%LetPub · 2026-09-13

Volume

Articles per year

112LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Average review time (community reports)

4–8 weeksLetPub · 2026-09-13

Average acceptance (community reports)

EasyLetPub · 2026-09-13

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Publisher

Elsevier Taiwan LLC

Country or region

TAIWAN

Language

English

Frequency

Monthly

Founded

2003

ISSN

1726-4901

Electronic ISSN

1728-7731

Latest issue on the website

Volume 89, Issue 8 (August 2026)

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗LetPub